UMN PHARMA INC. Inactive Instrument
UMN Pharma Inc. Stock
Equities
4585
JP3944320005
Biotechnology & Medical Research
More news
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - |
UMN Pharma Inc. is a Japan-based biotechnology company mainly engaged in the biopharmaceuticals development business. The Company is engaged in the development, manufacturing and sales of biopharmaceuticals based on the baculovirus expression vector system (BEVS) manufacturing platform. The Company's pipelines include seasonal influenza vaccine UMN-0502, pandemic influenza vaccine UMN-0501, pandemic influenza vaccine UMN-0901 and norovirus/rotavirus vaccine UMN-2003.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.30% | 102B | |
| +1.79% | 96.84B | |
| -0.44% | 21.48B | |
| -18.35% | 20.82B | |
| -7.45% | 18.6B | |
| -40.31% | 16.81B | |
| -26.84% | 13.78B | |
| +0.59% | 13.4B | |
| +20.86% | 11.06B |
